Arkolith/Insider Trading/PCVX/Form 4

Pickering Grant

CHIEF EXECUTIVE OFFICER, DirectorVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Mar 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Tax withholding(F)3K$61.98$157K501K
Feb 28, 2026Tax withholding(F)3K$61.98$177K503K
Feb 26, 2026Grant(A)105K—$0506K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 26, 2026Grant(A)176K—$0176K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001258693-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML